HLN:LON
Haleon PLC
GBXÂ 343.10
arrow_downward
-0.06%(-0.20) 1D
Sep 8, 11:03:17 AM GMT+1 · GBX
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLN...
Open
GBXÂ 342.20
High
GBXÂ 344.90
Low
GBXÂ 341.30
Mkt. cap
30.19B
Avg. vol.
19.67M
Volume
2.03M
Dividend
2.13%
Quarterly dividend
GBXÂ 1.83
Ex-dividend date
Aug 13, 2026
P/E ratio
18.93
52-wk high
GBXÂ 416.10
52-wk low
GBXÂ 274.40
EPS
GBXÂ 0.18
Shares outstanding
8.80B
No. of employees
25K
Open
GBXÂ 342.20
High
GBXÂ 344.90
Low
GBXÂ 341.30
Mkt. cap
30.19B
Avg. vol.
19.67M
Volume
2.03M
Dividend
2.13%
Quarterly dividend
GBXÂ 1.83
Ex-dividend date
Aug 13, 2026
P/E ratio
18.93
52-wk high
GBXÂ 416.10
52-wk low
GBXÂ 274.40
EPS
GBXÂ 0.18
Shares outstanding
8.80B
No. of employees
25K
News stories
From web sources and news partners
AD HOC NEWS
·
1 day ago
Haleon stock holds steady as consumer health revenues grow
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC